Research Keyword: PI3K inhibitors

Nutritional strategies in supporting immune checkpoint inhibitor, PI3K inhibitor, and tyrosine kinase inhibitor cancer therapies

mycolabadmin

This review examines how nutrition and food-based interventions can improve cancer treatment outcomes for patients receiving targeted cancer therapies. A Mediterranean-style diet with plenty of fiber (30-50g daily) appears beneficial for patients on immune checkpoint inhibitor therapies by promoting healthy gut bacteria that support immune function. The review also discusses promising research on fermented foods, specific bacterial supplements, mushroom extracts, and fasting approaches as complementary strategies to enhance cancer treatment effectiveness while reducing side effects.

Read More »

Invasive Cutaneous Mucormycosis in a Patient With Chronic Lymphocytic Leukemia on Obinutuzumab, Idelalisib, and Bruton Tyrosine Kinase Degrader: A Case Report

mycolabadmin

A 74-year-old man with blood cancer developed a serious fungal skin infection caused by Mucorales while taking multiple targeted cancer drugs. The infection appeared as a darkening ulcer on his ankle that rapidly worsened. Doctors diagnosed it using a skin biopsy showing characteristic fungal structures, though standard fungal tests came back negative. The patient required amputation of his leg below the knee to remove all the infected tissue, along with antifungal medications, and ultimately recovered.

Read More »
Scroll to Top